NPR's Brenda Wilson reports on the settlement of the pharmaceutical case in South Africa. The agreement will allow off-brand companies to manufacture and market drugs -- including those used for treating symptoms of AIDS -- in Africa, but with many strong restrictions.
Copyright 2001 NPR